Immune response of young children using ATP-based Cylex assay: a brief report

Archana Jayaram1, Adrianna Zeevi, Carol Bentlejewski

  • 1Professor of Pediatrics and Surgery, Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, PA15224,USA.

Insights

Young children under three years old show a robust immune response to mitogens, similar to older children. This study utilized the Cylex assay to measure ATP release, indicating T-cell function in pediatric immunity.

Area of Science:

  • Immunology
  • Pediatrics

Background:

  • Limited data exists on the immune responses of young children, particularly those under three years old.
  • Assessing T-cell function in this age group is crucial for understanding pediatric immune development.

Purpose of the Study:

  • To measure the immune response of healthy children under three years of age to common mitogens.
  • To evaluate the utility of the Cylex assay for assessing T-cell function in infants and toddlers.

Main Methods:

  • Blood samples were collected from 20 healthy children aged 10-27 months during routine healthcare visits.
  • The Cylex assay was employed to quantify Adenosine Triphosphate (ATP) production by CD4+ and CD3+ T-cells.
  • Cells were stimulated with phytohemagglutinin (PHA) and concanavalin A (Con-A) to assess T-cell responsiveness.

Main Results:

  • CD4+ T-cells demonstrated significant ATP production in response to PHA stimulation (mean 376 ng/mL), comparable to older children.
  • CD3+ T-cells showed measurable ATP production following Con-A stimulation (mean 114 ng/mL, median 93.3 ng/mL).
  • The results indicate a comparable mitogen response between young children and older cohorts.

Conclusions:

  • Despite an evolving immune system, young children (under three years) exhibit a functional immune response to mitogen stimulation.
  • The Cylex assay is a viable method for assessing T-cell immune responses in pediatric populations.
  • These findings contribute valuable data to the understanding of early-life immunity.

Related Concept Videos